Gene · 23532
Papers1,874
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,874
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| scAGCI: an anchor graph-based method for cell clustering from integrated scRNA-seq and scATAC-seq data. | Brief Bioinform | 2025 | 40622484 | PubTator, text mining | PubMed |
| CIC::DUX4 Sarcoma With Preferentially Expressed Antigen in Melanoma (PRAME) Immunopositivity. | Cureus | 2025 | 40599504 | PubTator, text mining | PubMed |
Unleashing the future of cancer immunotherapy: in silico design of a multi-epitope and mRNA vaccine duo targeting EWSR1-ATF1, EWSR1-CREB1, and PRAME to conquer clear cell sarcoma using immunoinformatics approaches. | Med Oncol | 2025 | 40581703 | PubTator, text mining | PubMed |
| Primary Cutaneous Melanoma With Sebocyte-like Melanocytes: Case Report and Review of the Literature. | Am J Dermatopathol | 2025 | 40569212 | PubTator, text mining | PubMed |
| Atypical Spitz Tumor (Spitz Melanocytoma) With Lymph Node Metastasis and Long-Term Clinical Follow-Up. | Am J Dermatopathol | 2025 | 40554668 | PubTator, text mining | PubMed |
| Atypical Spitz Tumor in a Pediatric Patient: A Case Report. | S D Med | 2025 | 40550168 | PubTator, text mining | PubMed |
| Management of Aggressive Acral Melanoma in a Pregnant Patient. | Cureus | 2025 | 40520839 | PubTator, text mining | PubMed |
| The Markers Auxiliary in Distinguishing Between Nodal Nevi and Melanoma Metastases. | Curr Med Chem | 2025 | 40511655 | PubTator, text mining | PubMed |
| Immunohistochemistry for Skin Cancers: New Insights into Diagnosis and Treatment of Melanoma. | Cancers (Basel) | 2025 | 40507250 | PubTator, text mining | PubMed |
| Preferentially Expressed Antigen in Melanoma (PRAME) as a diagnostic and predictive marker in melanocytic tumors: An updated narrative review. | Histol Histopathol | 2025 | 40495638 | PubTator, text mining | PubMed |
| Unmethylated PRAME DNA in tissue and plasma: a promising marker for melanoma. | Br J Dermatol | 2025 | 40460240 | PubTator, text mining | PubMed |
| PRAME is not a frequently expressed antigen in renal cell carcinoma. | BJUI Compass | 2025 | 40453487 | PubTator, text mining | PubMed |
| Malignant CRTC1::TRIM11 Cutaneous Tumor With Lethal Outcome: Histopathologic and Molecular Findings. | J Cutan Pathol | 2025 | 40452552 | PubTator, text mining | PubMed |
| Focal High-Grade Areas with a Tumor-in-Tumor Pattern: Another Feature of Pediatric DICER1-Associated Thyroid Carcinoma? | Endocr Pathol | 2025 | 40448797 | PubTator, text mining | PubMed |
| Correction to "Expression of Cancer-Testis Antigens MAGE-A1, MAGE-A4, NY-ESO-1 and PRAME in Bone and Soft Tissue Sarcomas: The Experience From a Single Center in China". | Cancer Med | 2025 | 40395161 | PubTator, text mining | PubMed |
| The combined diagnostic value of 5-hmC and PRAME immunohistochemistry in melanocytic neoplasms. | Pathol Res Pract | 2025 | 40328178 | PubTator, text mining | PubMed |
| Diagnostic Utility of Preferentially Expressed Antigen in Melanoma (PRAME) and p16 Immunohistochemistry in Distinguishing Genital Melanomas From Benign Melanocytic Proliferations. | Am J Dermatopathol | 2025 | 40314660 | PubTator, text mining | PubMed |
| Methylation-based test for diagnosis of benign and malignant melanocytoma. | Br J Dermatol | 2025 | 40314432 | PubTator, text mining | PubMed |
| Author Correction: Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial. | Nat Med | 2025 | 40301562 | PubTator, text mining | PubMed |
| Prognostic value of PRAME expression in uveal melanoma: a meta-analysis. | J Clin Pathol | 2025 | 40295098 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23532/papers?page=9